On Sunday, Israel withdrew part of its coronavirus vaccination shooting policy, saying that contrary to a recent announcement, cancer patients should be left with only two blows.
On Monday, Israel began administering a third shot of Pfizer / BioNTech inoculation to patients with compromised immune systems, including people who have had heart, lung and kidney transplants and some cancer patients.
But on Sunday, the ministries of health said that after reviewing data on hundreds of oncology ward patients, “the recommendation at this stage is not to vaccinate” cancer patients.
“Almost 90% of patients receiving chemotherapy developed antibodies after vaccination (two doses of) and the level of antibodies remained high a few months after vaccination,” he said in a “clarification” to the funds. health care and in hospital administrators the features.
“In addition, vaccination could have side effects … that could affect cancer treatment,” the ministry said.
Pfizer and BioNTech have said they would ask permission from US and European authorities to provide a third dose of their vaccine, but European regulators say it was too early to know if a third party was needed.
The World Health Organization has expressed concern that this booster may be at the expense of countries whose citizens have not yet received their first two doses.
The initial launch of Israeli vaccines into the Pfizer / BioNTech jab was one of the fastest in the world and helped reduce the cases confirmed daily to single digits last month.
He decided to continue with third shots in light of the evidence “that patients with immunosuppression do not develop an adequate antibody response after two doses” and after the number of daily cases began to increase.
A spokesman for Sheba Medical Center, Israel’s largest hospital, told AFP that “dozens” of cancer patients had received a third shot since Monday.
© 2021 AFP
Citation: Israel removes cancer patients from third retrieval list (2021, July 18) retrieved July 18, 2021 at https://medicalxpress.com/news/2021-07-israel-cancer-patients-vaccine- jab.html
This document is subject to copyright. Apart from any fair treatment for the purposes of private study or research, no part may be reproduced without written permission. Content is provided for informational purposes only.